GENT.OL Stock — Price, Charts & Analysis

Gentian Diagnostics ASA (GENT.OL) has no trailing P/E shown and a forward P/E of 15.04x. This places GENT.OL in a moderate earnings multiple territory based on the valuation data currently available on Worldtickers.

GENT.OL trades with 15.04x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether GENT.OL looks overvalued or undervalued.

GENT.OL's P/E of 15.04x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

GENT.OL's trailing EPS is -NOK 0.55 and forward EPS is NOK 2.58.

EPS, or earnings per share, shows how much profit Gentian Diagnostics ASA generated for each share. GENT.OL's trailing EPS is -NOK 0.55, and investors usually prefer EPS that is positive and growing over time.

Gentian Diagnostics ASA has a market cap of NOK 599.79M, making GENT.OL a small-cap stock based on the current market value shown on Worldtickers.

GENT.OL's latest stock price on Worldtickers is NOK 38.80. The latest move is NOK 1.20 or 3.19%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

GENT.OL's quote includes a latest price of NOK 38.80. The market open is NOK 37.60. Previous close is NOK 37.60. The intraday range is NOK 37.60 to NOK 38.80.

GENT.OL is up in the latest quote, with a move of NOK 1.20 or 3.19%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

GENT.OL generated NOK 182.12M in trailing revenue. Revenue growth is 14.20%, which helps show whether demand is expanding or slowing.

GENT.OL's revenue growth is 14.20%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

No, GENT.OL does not show positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is -NOK 8.41M.

Gross margin is 55.51%. Margins show how efficiently Gentian Diagnostics ASA turns revenue into profit.

Gentian Diagnostics ASA carries NOK 16.81M and holds NOK 79.34M in cash.

GENT.OL holds NOK 79.34M on its balance sheet.

GENT.OL's book value per share is NOK 11.82.

Yes, Gentian Diagnostics ASA pays a dividend of NOK 0.60 per share annually. The dividend yield is 160.00%. The payout ratio is 46.51%.

GENT.OL's dividend yield is 160.00%. Its payout ratio is 46.51%, which helps judge dividend sustainability. Dividend investors usually prefer a reasonable yield, consistent cash flow, and a payout ratio that leaves room for reinvestment.

Worldtickers does not currently show a confirmed next ex-dividend date for GENT.OL. The page does show dividend rate and yield when available, and investors should confirm record and payment dates through Gentian Diagnostics ASA's investor relations materials.

Institutions hold 40.11% of GENT.OL shares. Insiders hold 44.62% of shares. Ownership mix helps investors understand how much of Gentian Diagnostics ASA is held by professional investors and company insiders.

GENT.OL has 15.46M shares outstanding. Float shares are 7.28M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for GENT.OL, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for GENT.OL is NOK 2.58. Revenue growth is 14.20%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

GENT.OL's trailing EPS is -NOK 0.55. Forward EPS is NOK 2.58. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

GENT.OL is in the Healthcare sector. Its earnings multiple is 15.04x. Its latest displayed growth metric is 14.20%. Compare these figures with sector peers before deciding whether Gentian Diagnostics ASA is stronger or weaker than average.

GENT.OL trades at NOK 38.80. The stock trades at 15.04x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Gentian Diagnostics ASA's fundamentals.

GENT.OL risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.45, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

GENT.OL should be compared with companies in Medical Devices. Its earnings multiple is 15.04x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Gentian Diagnostics ASA (GENT.OL) operates in Healthcare, specifically Medical Devices. Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. It offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Calprotectin Immunoassay, a turbidimetric assay used for the measurement of circulating calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a GFR marker for the diagnosis and therapeutic control of re

GENT.OL trades on Oslo. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

GENT.OL stock is priced in NOK on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Gentian Diagnostics ASA's official website listed on Worldtickers is www.gentian.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Gentian Diagnostics ASA employs about 63 people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Gentian Diagnostics ASA is headquartered in Moss, Norway. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

GENT.OL is in the Healthcare sector and the Medical Devices industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

GENT.OL has traded between NOK 33.50 and NOK 60.00 over the past 52 weeks. At NOK 38.80, it is 35.33% below the high and 15.82% above the low. The 52-week range helps gauge long-term price momentum.

GENT.OL is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. Its 50-day moving average is NOK 38.23 and its 200-day moving average is NOK 45.02.

GENT.OL's RSI is 49.21. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

GENT.OL's latest RSI reading is 49.21, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for GENT.OL is near NOK 37.00. Key resistance is near NOK 40.90. Breaks above resistance or below support can change the short-term technical setup.

GENT.OL's nearest reported support level is NOK 37.00. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

GENT.OL's nearest reported resistance level is NOK 40.90. A breakout above resistance can improve momentum, especially when volume confirms the move.

GENT.OL trades about 4.52K shares daily on average. The latest displayed volume is 1.05K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

GENT.OL's MACD is -0.26, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

GENT.OL is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. RSI is 49.21 (neutral). MACD is bearish. Nearest support is around NOK 37.00. Resistance is around NOK 40.90. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is NOK 39.47 (-1.69% from price). MA50 is NOK 38.23 (1.48% from price). MA200 is NOK 45.02 (-13.82% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. GENT.OL's MA20 is NOK 39.47. MA50 is NOK 38.23. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

GENT.OL's pivot is near NOK 37.87. Support is near NOK 37.00. Resistance is near NOK 40.90. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for GENT.OL is near NOK 37.61. The next upper resistance zone is near NOK 40.75. These levels help define risk and possible follow-through zones after a breakout or breakdown.

GENT.OL's Bollinger range is roughly NOK 37.75 to NOK 41.18. Band width is near 8.71%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

GENT.OL's ATR-based typical daily range is about 3.61%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 1.05K shares. Average volume is about 4.52K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

GENT.OL's all-time high shown on Worldtickers is NOK 89.00. Its all-time low is NOK 22.00. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

GENT.OL has a beta of 0.45, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.